Mutant p53 in breast cancer: potential as a therapeutic target and biomarker.

Irene L. Andrulis, Nona C. R. Arneson, Susan J. Done, Hilmi Özçelik, Mark Redston, p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias Cancer Research. ,vol. 58, pp. 785- 789 ,(1998)

Mark Kriegsmann, Volker Endris, Thomas Wolf, Nicole Pfarr, Albrecht Stenzinger, Sibylle Loibl, Carsten Denkert, Andreas Schneeweiss, Jan Budczies, Peter Sinn, Wilko Weichert, Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences. Oncotarget. ,vol. 5, pp. 9952- 9965 ,(2014) , 10.18632/ONCOTARGET.2481

Lucy R Yates, Moritz Gerstung, Stian Knappskog, Christine Desmedt, Gunes Gundem, Peter Van Loo, Turid Aas, Ludmil B Alexandrov, Denis Larsimont, Helen Davies, Yilong Li, Young Seok Ju, Manasa Ramakrishna, Hans Kristian Haugland, Peer Kaare Lilleng, Serena Nik-Zainal, Stuart McLaren, Adam Butler, Sancha Martin, Dominic Glodzik, Andrew Menzies, Keiran Raine, Jonathan Hinton, David Jones, Laura J Mudie, Bing Jiang, Delphine Vincent, April Greene-Colozzi, Pierre-Yves Adnet, Aquila Fatima, Marion Maetens, Michail Ignatiadis, Michael R Stratton, Christos Sotiriou, Andrea L Richardson, Per Eystein Lønning, David C Wedge, Peter J Campbell, None, Subclonal diversification of primary breast cancer revealed by multiregion sequencing Nature Medicine. ,vol. 21, pp. 751- 759 ,(2015) , 10.1038/NM.3886

Mona Sobhani, Jahangir Abdi, Saha N Manujendra, Christine Chen, Hong Chang, PRIMA-1Met induces apoptosis in Waldenström's Macroglobulinemia cells independent of p53 Cancer Biology & Therapy. ,vol. 16, pp. 799- 806 ,(2015) , 10.1080/15384047.2015.1026482

Flore Kruiswijk, Christiaan F. Labuschagne, Karen H. Vousden, p53 in survival, death and metabolic health: a lifeguard with a licence to kill Nature Reviews Molecular Cell Biology. ,vol. 16, pp. 393- 405 ,(2015) , 10.1038/NRM4007

Pavla Bouchalova, Rudolf Nenutil, Petr Muller, Roman Hrstka, M Virginia Appleyard, Karen Murray, Lee B Jordan, Colin A Purdie, Philip Quinlan, Alastair M Thompson, Borivoj Vojtesek, Philip J Coates, Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status The Journal of Pathology. ,vol. 233, pp. 238- 246 ,(2014) , 10.1002/PATH.4356

Kathryn T. Bieging, Stephano Spano Mello, Laura D. Attardi, Unravelling mechanisms of p53-mediated tumour suppression Nature Reviews Cancer. ,vol. 14, pp. 359- 370 ,(2014) , 10.1038/NRC3711

Katherine A Hoadley, Christina Yau, Denise M Wolf, Andrew D Cherniack, David Tamborero, Sam Ng, Max DM Leiserson, Beifang Niu, Michael D McLellan, Vladislav Uzunangelov, Jiashan Zhang, Cyriac Kandoth, Rehan Akbani, Hui Shen, Larsson Omberg, Andy Chu, Adam A Margolin, Laura J Van’t Veer, Nuria Lopez-Bigas, Peter W Laird, Benjamin J Raphael, Li Ding, A Gordon Robertson, Lauren A Byers, Gordon B Mills, John N Weinstein, Carter Van Waes, Zhong Chen, Eric A Collisson, Christopher C Benz, Charles M Perou, Joshua M Stuart, None, Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin Cell. ,vol. 158, pp. 929- 944 ,(2014) , 10.1016/J.CELL.2014.06.049

Chiara Gorrini, Isaac S. Harris, Tak W. Mak, Modulation of oxidative stress as an anticancer strategy. Nature Reviews Drug Discovery. ,vol. 12, pp. 931- 947 ,(2013) , 10.1038/NRD4002

David Wynford-Thomas, P53 in tumour pathology: Can we trust immunocytochemistry? The Journal of Pathology. ,vol. 166, pp. 329- 330 ,(1992) , 10.1002/PATH.1711660402